Celsus secures private placement

Celsus Therapeutics (Nasdaq: CLTX) announced yesterday a $75 million private placement offering. The stock price more than tripled by rocketing $2.93 to close at $3.95.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.